- $4.00bn
- $4.00bn
- $3.10bn
Annual balance sheet for Minimed, fiscal year end - April 24th, millions except per share.
2023 April 28th | 2024 April 26th | 2026 April 24th | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | ||
| Standards: | — | USG | — |
| Status: | fx Preliminary | Final | fx Preliminary |
| Cash and Equivalents | |||
| Cash and Short Term Investments | — | 54 | — |
| Net Total Accounts Receivable | |||
| Net Total Receivables | — | 507 | — |
| Total Inventory | |||
| Total Other Current Assets | |||
| Total Current Assets | — | 895 | — |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | — | 684 | — |
| Net Goodwill | |||
| Net Intangible Assets | |||
| Long Term Investments | |||
| Long Term Notes Receivable | |||
| Other Long Term Assets | |||
| Total Assets | — | 4,094 | — |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | — | 518 | — |
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | — | 646 | — |
| Other Equity | |||
| Total Equity | — | 3,448 | — |
| Total Liabilities & Shareholders' Equity | — | 4,094 | — |
| Total Common Shares Outstanding |